TABLE 1.
Honey products used in this study.
| Product name | Product description | Initial IC90 for Escherichia coli K‐12 MG1655 | Manufacturer | Purchased from |
|---|---|---|---|---|
| SurgihoneyRO™ | Medical honey; sterile, bio‐engineered; undiluted; single‐origin (unspecified) | 4%(w/v) | Matoke Holdings Ltd, Abingdon, United Kingdom | tubes of 20 g and 50 g: H&R Healthcare, Hull, United Kingdom |
| Medihoney™ Antibacterial Medical Honey | Medical honey; sterile, undiluted; Leptospermum honey (methylglyoxal content unspecified) | 12.8%(w/v) | Sorbion Austria, Zwölfaxing, Austria | tubes of 20 g: Puras AG, Bern, Switzerland; tubes of 50 g: The Honeydoctor, The Littledart Company Ltd, Tiverton, United Kingdom, and puravita ag, Speicher, Switzerland |
| Manuka Honey MGO™550+ | Consumer product; natural, undiluted; Leptospermum honey (methylglyoxal content of 550 mg/kg) | 8%(w/v) | Manuka Health New Zealand Ltd, Te Awamutu, New Zealand | 250 g jars: nu3 GmbH, Berlin, Germany |
| Commercial honey (Fairtrade Liquid Blossom Honey) | Consumer product; natural, undiluted; poly‐origin (Chili, Guatemala, (Mexico)) | 8%(w/v) | Coop, Basel, Switzerland | 550 g jars: Coop, Basel, Switzerland |